With COVID boosters expected to cost £100 when they go on sale in UK pharmacies, there are concerns about whether this will put people off getting the jab.
Articles on Hybrid immunity
Displaying all articles
As COVID finds its equilibrium, infection rates will rise and fall, influenced by seasons, school holidays and new subvariants. Managing the risk is complex and needs to be cost effective.
There’s pretty much no one left in the US who hasn’t been exposed to the coronavirus, whether by vaccination, infection or both.
The decision to remove the testing requirement for international arrivals seems shortsighted. All outbreaks in Aotearoa have been caused by new variants coming across the border.
As New Zealand emerges from its Omicron wave, increasing hybrid immunity and access to antivirals mean it’s time to shift the focus of COVID management.
Case numbers are falling in all age groups, including over-70s. This is good news as case rates in older people have been a key driver of the steep rise in hospitalisations and deaths in this wave.
Achieving herd immunity via vaccination was always going to be a hard ask. Now it’s mathematically impossible.
Because COVID-19 is a relatively new virus, researchers still aren’t sure exactly how long vaccines and prior infections provide protection.
Top contributors
-
Professor in Applied Mathematics, University of Canterbury
-
Senior Lecturer, University of Auckland, Waipapa Taumata Rau
-
Professor in Mathematical Biology, The University of Melbourne
-
Personal Chair of Immunopathology, University of Edinburgh
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Biology, the Emerging Pathogens Institute, University of Florida
-
Associate Professor Immunology and Microbiology and Clinical Microbiologist, University of Otago
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Associate Professor Primary Health, University of Auckland, Waipapa Taumata Rau
-
Research Fellow, Epidemic Decision Support, The University of Melbourne
-
Medical adviser immunisation, University of Auckland, Waipapa Taumata Rau
-
Professor and Webster Family Chair in Viral Pathogenesis, University of Otago
-
Assistant Professor of Biostatistics, University of Florida
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Head of School of Population Health and Professor, Infectious Diseases Dynamics and Interventions, UNSW